Document:

EX-10.2

 Exhibit 10.2 

AMENDMENT 
 TO THE

 1998 OUTSIDE DIRECTOR STOCK COMPENSATION PLAN 

WHEREAS, on June 15, 2014, Medtronic, Inc. (“Medtronic”) entered into a Transaction Agreement with Covidien plc and the
other parties named therein (the “Transaction Agreement”) to acquire Covidien through the formation of a new holding company incorporated in Ireland that will be renamed Medtronic plc (the “Transaction”); and 

WHEREAS, Medtronic maintains the 1998 Outside Director Stock Compensation Plan (the “Director Stock Plan”); and 

WHEREAS, in connection with the Transaction, the Director Stock Plan is being assumed by Medtronic plc and certain technical changes are
required in connection with the Transaction and assumption. 
 NOW THEREFORE, the Director Stock Plan shall be and hereby is amended in the
following respects, effective as of the Effective Time (as defined in the Transaction Agreement): 
  

	 	1.	References to “Medtronic, Inc.” are hereby replaced with references to “Medtronic plc”. 

  

	 	2.	“Affiliate” is hereby defined to mean a corporation or other entity controlled by, controlling, or under common control with, the Company. 

 

	 	3.	The following language is hereby added to the end of the definition of “Change in Control”: “For the avoidance of doubt, any one or more of the above events may be effected pursuant to (A) a
compromise or arrangement sanctioned by the court under section 201 of the Companies Act 1963 of the Republic of Ireland or (B) section 204 of the Companies Act 1963 of the Republic of Ireland.” 

 

	 	4.	“Company” is hereby defined to mean Medtronic plc, an Irish public limited company. 

  

	 	5.	“Share” is hereby defined to mean an ordinary share of the Company, $0.0001 par value per share. 

  

	 	6.	“Subsidiary” is hereby defined as having the meaning set forth in section 155 of the Companies Act 1963 of the Republic of Ireland; provided that, to the extent required to avoid the imposition of additional
taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a “controlling interest” (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)),
either directly or through a chain of corporations or other entities in which each corporation or other entity has a “controlling interest” in another corporation or entity in the chain, as determined by the Committee. 

	 	7.	The following language is hereby added to the beginning of the second sentence in Section 5(d): “To the extent permitted by applicable law,” 

 

	 	8.	Section 8 is hereby amended to add the following language at the end thereof as a new Section 8(e): 

(e) Special Rules for Deferred Stock Units. Section 8 of the Plan, as in effect prior to Effective Time, credited to certain
Participants a number of Deferred Stock Units and permitted each such Participant to defer delivery of the Shares from the Participant’s Account. Effective as of the Effective Time, all credits of Deferred Stock Units shall cease and no new
Accounts are permitted to be established under the Plan. The Company shall continue to maintain and administer the Accounts established prior to the Effective Time, according to Section 8 of the Plan as in effect immediately prior to the
Effective Time. 
  

	 	9.	The following language is hereby added to the first sentence of Section 9(f) before the words “through a Fundamental Change”: “or any other alteration to the capital structure of the Company,
whether”. 

  

	 	10.	The following language is hereby added to the end of the first sentence of Section 9(f): “, provided that in no event shall the per Share exercise price of an Option or the subscription price payable per Share
of an Award be reduced to an amount that is lower than the nominal value of a Share.” 

  

	 	11.	The following language is hereby added to the end of Section 9(i): “Notwithstanding any other provision of this Plan, the Company shall not obliged to issue or deliver any Shares in satisfaction of Awards
until all legal and regulatory requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee.” 

  

	 	12.	The following language is hereby added to the end of the first sentence of Section 9(j): “to the extent permitted by applicable law”. 

  
 2EX-10.3

 Exhibit 10.3 

AMENDMENT 
 TO THE

 2003 LONG-TERM INCENTIVE PLAN 

WHEREAS, on June 15, 2014, Medtronic, Inc. (“Medtronic”) entered into a Transaction Agreement with Covidien plc and the
other parties named therein (the “Transaction Agreement”) to acquire Covidien through the formation of a new holding company incorporated in Ireland that will be renamed Medtronic plc (the “Transaction”); and 

WHEREAS, Medtronic maintains the 2003 Long-Term Incentive Plan (the “2003 Plan”); and 

WHEREAS, in connection with the Transaction, the 2003 Plan is being assumed by Medtronic plc and certain technical changes are required in
connection with the Transaction and assumption. 
 NOW THEREFORE, the 2003 Plan shall be and hereby is amended in the following respects,
effective as of the Effective Time (as defined in the Transaction Agreement): 
  

	 	1.	References to “Medtronic, Inc.” are hereby replaced with references to “Medtronic plc”. 

  

	 	2.	The following language is hereby added to the end of the definition of “Change in Control”: For the avoidance of doubt, any one or more of the above events may be effected pursuant to (A) a compromise or
arrangement sanctioned by the court under section 201 of the Companies Act 1963 of the Republic of Ireland or (B) section 204 of the Companies Act 1963 of the Republic of Ireland. 

 

	 	3.	“Company” is hereby defined to mean Medtronic plc, an Irish public limited company. 

  

	 	4.	“Shares” is hereby defined to mean ordinary shares of the Company, $0.0001 par value per share. 

  

	 	5.	“Subsidiary” is hereby defined as having the meaning set forth in section 155 of the Companies Act 1963 of the Republic of Ireland; provided that, to the extent required to avoid the imposition of additional
taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a “controlling interest” (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)),
either directly or through a chain of corporations or other entities in which each corporation or other entity has a “controlling interest” in another corporation or entity in the chain, as determined by the Committee. 

 

	 	6.	The following language is hereby added to the beginning of the third sentence in Section 6(c): “To the extent permitted by law,”. 

	 	7.	The following language is hereby added to the beginning of the fourth sentence in Section 7(b): “To the extent permitted by law,”. 

 

	 	8.	The following language is hereby added to the end of the first sentence of Section 11(a): “, provided that in no event shall the per Share exercise price of an Option or the subscription price payable per
Share of an Award be reduced to an amount that is lower than the nominal value of a Share.” 

  

	 	9.	A new section 18(f) is hereby added containing the following language: 

 Irish Conditions
for Issuance. Notwithstanding any other provision of this Plan, (a) the Company shall not be obliged to issue any Shares pursuant to an Award unless at least the par (nominal) value of such newly issued Share has been fully paid in
advance in accordance with applicable law (which requirement may mean the holder of an Award is obliged to make such payment) and (b) the Company shall not obliged to issue or deliver any Shares in satisfaction of Awards until all legal and
regulatory requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee. 

  
 2EX-10.4

 Exhibit 10.4 

AMENDMENT 
 TO THE

 2008 STOCK AWARD AND INCENTIVE PLAN 

WHEREAS, on June 15, 2014, Medtronic, Inc. (“Medtronic”) entered into a Transaction Agreement with Covidien plc and the
other parties named therein (the “Transaction Agreement”) to acquire Covidien through the formation of a new holding company incorporated in Ireland that will be renamed Medtronic plc (the “Transaction”); and 

WHEREAS, Medtronic maintains the 2008 Stock Award and Incentive Plan (the “2008 Plan”); and 

WHEREAS, in connection with the Transaction, the 2008 Plan is being assumed by Medtronic plc and certain technical changes are required in
connection with the Transaction and assumption. 
 NOW THEREFORE, the 2008 Plan shall be and hereby is amended in the following respects,
effective as of the Effective Time (as defined in the Transaction Agreement): 
  

	 	1.	References to “Medtronic, Inc.” are hereby replaced with references to “Medtronic plc”. 

  

	 	2.	The following language is hereby added to the end of the definition of “Change of Control”: “For the avoidance of doubt, any one or more of the above events may be effected pursuant to (A) a
compromise or arrangement sanctioned by the court under section 201 of the Companies Act 1963 of the Republic of Ireland or (B) section 204 of the Companies Act 1963 of the Republic of Ireland.” 

 

	 	3.	“Company” is hereby defined to mean Medtronic plc, an Irish public limited company. 

  

	 	4.	“Common Stock” is hereby defined to mean ordinary shares, par value $0.0001, of the Company. 

  

	 	5.	“Subsidiary” is hereby defined as having the meaning set forth in section 155 of the Companies Act 1963 of the Republic of Ireland; provided that, to the extent required to avoid the imposition of additional
taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a “controlling interest” (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)),
either directly or through a chain of corporations or other entities in which each corporation or other entity has a “controlling interest” in another corporation or entity in the chain, as determined by the Committee. 

 

	 	6.	The following language is hereby added to the end of the first sentence of Section 3.4(b): “, provided that in no event shall the per Share exercise price of an Option or the subscription price payable per
Share of an Award be reduced to an amount that is lower than the nominal value of a Share.” 

	 	7.	The following language is hereby added to the beginning of the third sentence in Section 5.8: “To the extent permitted by law and”. 

 

	 	8.	Section 12.1 is hereby deleted in its entirety and replaced with the following language: 

12.1 Effectiveness. The Effective Date of the Plan is June 26, 2008. 

 

	 	9.	Section 13.1 is hereby amended to add the following language to the beginning of the sentence: “Subject to applicable law,”. 

 

	 	10.	The following language is hereby added to the end of the second sentence in Section 15.4: “and to the extent permissible under applicable law.” 

 

	 	11.	Section 15 is hereby amended to add the following language at the end thereof as a new sub-section 15.22: 

Irish Conditions for Issuance. Notwithstanding any other provision of this Plan, (a) the Company shall not be obliged to issue any
Shares pursuant to an Award unless at least the par (nominal) value of such newly issued Share has been fully paid in advance in accordance with applicable law (which requirement may mean the holder of an Award is obliged to make such payment) and
(b) the Company shall not obliged to issue or deliver any Shares in satisfaction of Awards until all legal and regulatory requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee. 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]